-
-
-
-
-
-
-
Myovant Sciences Ltd. (MYOV) PT Raised to $55 at Evercore ISI, Following Positive Study Results
-
-
-
-
-
-
-
Evercore ISI Starts Savara (SVRA) at Outperform, Sees ~300% Upside
-
-
-
-
-
-
-
Theravance Biopharma (TBPH): The Next Incyte - Piper Jaffray
-
-
-
-
-
-
-
BioMarin Pharma (BMRN): Executing Well But For How Long - Piper Jaffray
-
-
-
-
-
-
-
Audentes Therapeutics (BOLD): Initiating Coverage with an Outperform Rating - Piper Jaffray
-
-
-
-
-
-
-
Nektar Therapeutics (NKTR): String of Catalysts Spurs PT Increase - Piper Jaffray
-
-
-
-
-
-
-
Piper Jaffray's GenomeRx Symposium Highlights a Field on the Verge of Breaking Out (BMRN) (QURE) (ONCE) (AVXS)
-
162 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

